Michael Triplett

Michael Triplett Managing Member at 18 Wiveliscombe

Dr. Michael Triplett is a co-founder and Managing Member of 1787 Bio, LLC, a life sciences investment organization based in Columbus, Ohio, and President of Carmen Partners LLC, a life science ventures, commercialization, and innovation consultancy. Dr. Triplett co-founded and served as President and CEO of Myonexus Therapeutics, a clinical stage gene therapy company developing first-ever treatments for limb-girdle muscular dystrophies. Sarepta Therapeutics (SRPT) acquired Myonexus Therapeutics for >$225 million in April 2019.

Dr. Triplett began his career at Procter & Gamble as a Product Development Engineer prior to attending graduate school. After completing his graduate work in nanoparticle engineering as a U.S. Department of Defense National Defense Science and Engineering Graduate Fellow, he joined Battelle where he held roles of progressing responsibility, spanning business development, innovation, new venture development, corporate ventures, and strategy for the Health & Life Sciences Global Business. Prior to co-founding Myonexus Therapeutics, Dr. Triplett served as Chief Executive Officer of N8 Medical, a clinical stage combination device company with Breakthrough designation for its lead combination medical device product.

Excelling at the interfaces of business and innovation, Dr. Triplett is passionate about translating world-class science and technology into transformative businesses, products, and capabilities that enhance human health, American competitiveness, and economic opportunity. Dr. Triplett focuses on life sciences technology ventures, innovation, technology-based economic development, and science, technology, engineering and math (STEM) education.

Dr. Triplett is currently leading an InnovateOhio Life Sciences Working Group for Ohio Lieutenant Governor Jon Husted with the mission to propose life sciences specific economic development strategies for the State of Ohio.

Dr. Triplett received his B.S. in Chemical Engineering (summa cum laude) and Ph.D. in Chemical Engineering from The Ohio State University.